Search
Sumario de resultados
TIpos de contenido
Fecha
-
CompanyBIOCLONAL
-
CompanyBIOCLONAL
-
NewORYZON presents blinded aggregate safety data from vafidemstat’s ongoing Phase IIb PORTICO...
At the 36th European College of Neuropsychopharmacology congress (ECNP-2023).
-
NewBiotechnology emerges as a key industry in the future strategy of the European Union
During the 5th and 6th of October 2023, Granada hosted meetings of the European Political Community (EPC) and the heads of state or government of the EU, where the strategic priorities for the future
-
AllyUNGRIA Patentes y Marcas
Founded in 1891, UNGRIA Patentes y Marcas, S.A. is a European law firm, with presence in Spain, USA and Latin America, specialized in Intellectual Property and related fields with more than 130 years
-
NewRenalyse has successfully closed an investment round of 1 M€ in public and private capita...
The operation was led by the Mind the Gap program from Botín Foundation, with participation from GENESIS Ventures and the Eurostars program.
-
NewADmit therapeutics closes a €5.4 million funding round led by Clave Capital, through its C...
The European Innovation Council (EIC) Fund and the Alzheimer's Drug Discovery Foundation (ADDF) Diagnostic Accelerator (DxA) join the round, alongside other investors such as Lavanda Ventures, Ship2B
-
New#NewMemberAseBio | "AseBio is an opportunity to help organizations in the sector understan...
Meet ProductLife Group, our new partner. We spoke with Wendy Morales, business development manager.
-
NewSimulation tools drive the new generation of therapies based on gene silencing
Researchers at Nostrum Biodiscovery, with the collaboration of other companies, have laid the groundwork for the systematic development of optimal RNA-binding inhibitors based on antisense
-
EventTraining course on Advanced Therapy Medicinal Products (ATMPs)
This course will review the role and evolution of the most relevant Regulatory Agencies, the different procedures and guideline that support the development of Advanced Therapy Medicinal Products (
-
New"Silence kills"
Studies indicate that more than 60 percent of medication errors are caused by mistakes in interpersonal communication.
-
NewBCN HEALTH publishes a study evaluating the incidence, mortality and medical costs associa...
BCN HEALTH conducted a retrospective study based on the records of patients diagnosed with a melanoma and treated in Spanish public and private hospitals between January of 2011 and December of 2017.
-
NewGallery | This is how #BIOSPAIN2023 went
BIOSPAIN 2023 brought together the global biotechnology industry in Barcelona and concluded its eleventh edition with record-breaking participation numbers. Over 2,100 attendees and more than 220
-
New"BIOSPAIN allows the creation of a sense of belonging to a leading sector that is already ...
BIOSPAIN, the largest biotechnology event organised by a national bioindustry association in Europe, closed its XI edition in Barcelona on 28 September after three days of events with AseBio as
-
NewORYZON receives two grants to further explore the role of epigenetic targets in the treatm...
Two collaborative projects with public research centers with a global budget of 2.3 million euros.
-
NewORYZON to provide corporate progress updates at several events in October
Oryzon Genomics, S.A., a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, announced today that its management will give
-
NewHOFFMANN EITLE Madrid & Barcelona celebrate their 10th anniversary in BIOSPAIN
As part of BIOSPAIN, from 26 to 28 September in Barcelona, HOFFMANN EITLE Madrid & Barcelona celebrated its tenth anniversary with a cocktail party that brought together clients, representatives of
-
NewBIOSPAIN 2023 concludes its eleventh edition with record-breaking attendance
Over 2,100 attendees and more than 220 exhibitors gathered over the course of the three-day congress.
-
Press releaseBIOSPAIN 2023 concludes its eleventh edition with record-breaking participation figures
The President of the Generalitat de Catalunya, Pere Aragonès i Garcia, and the General Manager of Amgen and member of the Board of Directors of AseBio and the Board of Trustees of Biocat, Fina Lladós
-
NewGenome editing techniques can help address the challenges facing agriculture and the plane...
Biotechnology enables the transformation of certain types of waste into raw materials for industry, avoiding their disposal in landfills and reducing the footprint of processes and products.
-
Press releaseGenome editing techniques can help address the challenges facing agriculture and the plane...
Ensuring food security and mitigating the impacts of climate change will not be possible without innovation in agriculture. Through food waste and the insect industry, proteins are being produced in a